Cuvposa
Generic name: Glycopyrrolate(GLY Koe PIE Roe Late)
Drug class:
Anticholinergics / antispasmodics
Usage of Cuvposa
Cuvposa belongs to a class of drugs known as anticholinergics.
Cuvposa inhibits acetylcholine receptors that are located on certain organs in the body, including salivary glands. Glycopyrrolate indirectly reduces the rate of saliva production by preventing the stimulation of these receptors.
Cuvposa is used to reduce drooling in children ages 3 to 16 who have certain medical conditions, such as cerebral palsy.
Cuvposa side effects
Get emergency medical help if you have signs of an allergic reaction to Cuvposa: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using Cuvposa and call your doctor at once if you have:
Common Cuvposa side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Cuvposa
You should not use Cuvposa if you are allergic to glycopyrrolate, or if you have:
To make sure Cuvposa is safe for you, tell your doctor if you have ever had:
It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
You should not breastfeed while using Cuvposa. Glycopyrrolate may slow breast milk production.
Do not give this medicine to a child without medical advice.
Relate drugs
- Antispasmodic
- Cuvposa
- Belladonna alkaloids and phenobarbital
- Belladonna/Phenobarbital
- Bentyl
- Cantil
- Chlordiazepoxide and clidinium
- Dartisla ODT
- Dicyclomine
- Digex NF
- Donnatal
- D-Tal
- Hyoscyamine
- Hyoscyamine and phenyltoloxamine
- Levsin
- Librax
- Mepenzolate
- Methscopolamine
- Pamine
- Pamine Forte
- Phenobarbital with Belladonna Alkaloids
- Pro-Banthine
- Propantheline
- RE-PB Hyos
- Robinul
- Robinul Forte
- Se-Donna PB Hyos
How to use Cuvposa
Usual Pediatric Dose for Excessive Salivation:
1 mg/5 mL oral liquid, children 3 to 16 years: Initial dose: 0.02 mg/kg orally 3 times a day, at least one hour before or 2 hours after meals -Titrate in increments of 0.02 mg/kg every 5 to 7 days, based on response and adverse effects Maximum dose: 0.1 mg/kg 3 times a day, not to exceed 1.5 to 3 mg per dose based on weight Use: To reduce chronic severe drooling in patients aged 3 to 16 years with conditions associated with problem drooling (e.g. cerebral palsy)
Warnings
You should not use Cuvposa if you have urination problems, a blockage in your stomach or intestines, severe constipation, severe ulcerative colitis or toxic megacolon, glaucoma, myasthenia gravis, or active bleeding with heart and blood circulation problems.
Before you take Cuvposa, tell your doctor if you have kidney disease, heart disease, a heart rhythm disorder, a stomach disorder, a colostomy or ileostomy, a thyroid disorder, high blood pressure, vision problems, or numbness and tingling.
What other drugs will affect Cuvposa
Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.
Tell your doctor about all your other medicines, especially:
This list is not complete. Other drugs may interact with glycopyrrolate, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions